Microtransplantation: a new hope for advanced cancer patients?

NCT ID NCT07356856

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-stage trial tests a procedure called microtransplantation (MST) combined with chemotherapy in 10 adults with advanced or relapsed solid tumors. The goal is to see if MST can help control the disease and improve recovery of blood cells after chemo. The study focuses on safety and how well the treatment works.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

More trials for these conditions

Other studies related to the condition(s) this trial covers.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Innovvy(Beijing) Biomedical Technology Co., Ltd

    Haidian, Beijing Municipality, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Minzu Hospital of Guangxi Zhuang Autonomous Region

    Nanning, Guangxi, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • The First People's Hospital of Nanning

    Nanning, Guangxi, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact